Martijn Schuemie

Janssen Research and Development, New Jersey, United States

Janssen R&D (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• OP-26C - Sensitivity Analysis of Design Choices for Estimating Incidence Rates of Adverse Events of Special Interest in Vaccine Safety

  Monday, August 23, 2021
  1:45 PM - 3:30 PM US Eastern Time

• L-1F - Residual Bias and Indirect Covariate Balance in an Applied Comparison of Large-scale Propensity Score and Cardinality Matching

  Monday, August 23, 2021
  5:30 PM - 6:30 PM US Eastern Time

• OP-5A - Descriptive Epidemiology of Adverse Events of Special Interest for COVID-19 Vaccines Across 7 Countries and 4 Continents: A Multinational Network Cohort Study

  Wednesday, August 25, 2021
  11:45 AM - 1:30 PM US Eastern Time